SBI Securities’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4 Hold
3
– – ﹤0.01% 4069
2026
Q2
$6 Sell
3
-2
-40% -$6 ﹤0.01% 3973
2026
Q1
$16 Buy
5
+1
+25% +$4 ﹤0.01% 3800
2025
Q4
$17 Hold
4
– – ﹤0.01% 3808
2025
Q3
$156 Hold
4
– – ﹤0.01% 3399
2025
Q2
$93 Sell
4
-2
-33% -$47 ﹤0.01% 3562
2025
Q1
$86 Sell
6
-1
-14% -$15 ﹤0.01% 3494
2024
Q4
$129 Hold
7
– – ﹤0.01% 3383

Other funds holding TVRD

SBI Securities's TVRD Position: Q3 2026 in Review

SBI Securities held its Tvardi Therapeutics (TVRD) position steady in Q3 2026 at 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #4069.

SBI Securities first reported a position in TVRD in Q4 2024 and has held it in 8 quarters since. The position peaked at $156 in Q3 2025. 62 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.

  • SBI Securities held 3 shares of Tvardi Therapeutics worth $4 as of Q3 2026.
  • SBI Securities left its Tvardi Therapeutics share count unchanged in Q3 2026.
  • Tvardi Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #4069 holding.
  • SBI Securities first reported a position in Tvardi Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Tvardi Therapeutics position peaked at $156 in Q3 2025.
  • 62 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.